Stock·NASDAQ·Real Estate
Equinix Inc (EQIX)
- Market cap
- $95.48B
- P/E
- 62.27
- Dividend yield
- 2.08%
- Street target
- $1,237.50median of 35 analysts
- 52-week range
- $720.62 $1,128.68
EQIX stock forecast today
Where EQIX stands today, and what CleaRank Financial AI makes of it.
EQIX at a glance
Equinix Inc (EQIX): Hold, 49/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($1,027.97 and $1,006.37).
- Earnings EQIX beat estimates in 6 of its last 8 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $66.0M and made no open-market purchases over the last 18 months.
- Valuation P/E of 62.3 against 44.7 for the Real Estate sector: a premium to peers (+39%).
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates Equinix Inc (EQIX) Hold, with a model score of 49/100.
The analysts' outlook lifts the score most: 30 of 35 analysts rate it a buy and the median target is 27.9% above the price. Momentum holds it back most: the 14-day RSI of 39.3 is in the bearish zone and the MACD line is negative. The trend is down: EQIX trades 5.87% below its 50-day average of $1,027.97 and 3.85% below its 200-day average of $1,006.37. Over the past year the price rose 15.27%.
Only on CleaRank
Figures we compute ourselves from EQIX's own price, earnings and insider-filing history. Tap one to see it in context.
EQIX stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
2/4Price above its 50-day average ›
The price of $967.65 is 5.9% below the 50-day simple moving average of $1,027.97.Price above its 200-day average ›
The price is 3.8% below the 200-day simple moving average of $1,006.37.50-day average above the 200-day ›
The 50-day average ($1,027.97) is 2.1% above the 200-day average ($1,006.37), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 61% of its 52-week range, between $720.62 and $1,128.68.
EQIX share price
Pick a period: each tab shows how far EQIX has moved over it, to the last close.
Today's trading
Where EQIX sits inside today's range and its 52-week range.
EQIX fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 62.27 is 39.3% above the Real Estate median of 44.7.P/S below the sector median ›
The price-to-sales ratio of 9.64 is 7.3% below the sector median of 10.4.Profitable over the last 12 months ›
Net income over the last 12 months was $1.5B on revenue of $9.9B, a net margin of 15.5%.Beat estimates in most recent reports ›
EQIX beat the EPS estimate in 6 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 2.08%, or $20.17 a share a year.
Key statistics
The headline figures for EQIX.
As of October 26, 2026, EQIX trades at $967.65, with a market value of $95.48B, a P/E ratio of 62.27 and a dividend yield of 2.08%.
What the numbers say
CleaRank Financial AI's reading of EQIX's valuation, growth and risks.
Equinix Inc (EQIX) trades on a trailing P/E of 62.27, while the Real Estate median is 44.7. That leaves its P/E 39.3% above the sector median P/E, and the peer comparison on this page calls it a premium to peers. On sales, the P/S of 9.64 sits 7.3% below the sector median P/S of 10.4. Trailing earnings stand at $15.54 per share.
Profitability shows a net margin of 15.48% and an operating margin of 27.02%. It generates a return on equity of 10.74%, above the sector median of 5.8%. It also reports debt-to-equity of 1.62 and a trailing dividend yield of 2.08% ($20.17 a share a year).
EQIX reported EPS of $5.10 in its most recent earnings report, dated July 29, 2026. Analysts had expected $4.80, so the company beat the estimate by 6.25%. The share price moved up 3.92% in the following session.
Equinix has beaten EPS estimates in 6 of the last 8 reports, yet the stock still fell in the first session after 3 of those 6 beats. Further back, the stock rose 10.41% after the February 11, 2026 report, which missed the estimate by 13.14%. Analysts look for EPS of $17.71 this fiscal year, up 20.8%, and $18.53 the year after, up 4.6%.
Valuation leaves less margin for error: the P/E of 62.27 is 39.3% above the sector median, a premium to peers. On a typical day the price of EQIX shifts by 1.58%, the 30-day standard deviation of its daily returns; measured against the S&P 500, its beta is 0.97. The downtrend is itself a risk for as long as the price stays under both moving averages. Over the last 18 months, insider sales totalled $66.0M with no open-market purchases; planned sales and tax sales on vesting shares make selling a weaker signal than buying.
EQIX against the Real Estate sector
How EQIX compares with the median Real Estate stock CleaRank tracks.
Price to earnings vs sector: EQIX trades at a significant premium to sector peers (+39%), suggesting market expectations for superior growth or market position.
Return vs XLRE: Since May 14, 2025, EQIX has gained 12.6% against a gain of 5.1% for XLRE.
Performance against XLRE
EQIX and the Real Estate sector fund over the same days.
Revenue and earnings
How much EQIX sells, and how much of it becomes profit.
Revenue growth: Revenue grew 5.4% in FY2025 to $9.2B, from $8.7B a year earlier.
Profit margin: The net margin was 14.6% in FY2025, up from 9.3% the year before.
Profitable: EQIX earned $1.3B in FY2025.
Earnings reality check
Did EQIX beat what analysts expected, and how did the stock react?
Earnings record: EQIX beat the analyst estimate in 6 of the last 8 quarters.
Market reaction: The stock fell in the first session after 3 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 29, 2026after close | $4.80 | $5.10 | +6.25% | +3.92% | +4.78% |
| Apr 29, 2026after close | $4.33 | $4.17 | -3.70% | -0.57% | -0.10% |
| Feb 11, 2026after close | $3.88 | $3.37 | -13.14% | +10.41% | +5.82% |
| Oct 29, 2025after close | $3.43 | $3.89 | +13.41% | +4.44% | +3.06% |
| Jul 30, 2025after close | $3.44 | $3.79 | +10.17% | -1.49% | -3.02% |
| Apr 30, 2025after close | $2.97 | $3.59 | +20.88% | +0.14% | +1.36% |
| Feb 12, 2025after close | $2.74 | $2.97 | +8.39% | -1.30% | +0.54% |
| Oct 30, 2024after close | $2.96 | $3.10 | +4.73% | -0.24% | -2.13% |
As of October 26, 2026, EQIX has beaten the analyst EPS estimate in 6 of its last 8 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on July 29, 2026, came in 6.25% above the estimate and the stock moved +3.92% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
EQIX AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 39.3, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 39.3 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of EQIX
The score, the reasoning behind it, and what could move the price next.
EQIX is priced at $967.65, below both of its main moving averages. It sits 5.87% under its 50-day average of $1,027.97 and 3.85% under its 200-day average of $1,006.37. Within its 52-week range, which runs from $720.62 up to $1,128.68, the price stands at 61%.
A recent pullback sits inside a stronger longer record: the price fell 4.01% over the past month, fell 7.56% over the past three months and rose 15.27% over the past year. On momentum, the 14-day RSI reads 39.3, in the bearish zone, above the oversold line, with the MACD line negative.
Earnings beat ›
The July 29, 2026 report beat the EPS estimate by 6.25%, and the share price rose 3.92% in the first session after it.
Source: Earnings report, July 29, 2026New analyst coverage ›
Rothschild & Co started coverage at Buy on September 21, 2026.
Source: Analyst action, Rothschild & Co, September 21, 2026
New analyst coverage ›
CIBC started coverage at Outperformer on October 21, 2026.
Source: Analyst action, CIBC, October 21, 2026
- The two nearest levels matter most: the 20-day EMA at $996.75 sits above the price, and the 52-week low at $720.62 sits below it.
- The 14-day RSI reads 39.3, in the bearish zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- The share price rose 3.92% in the first session after the July 29, 2026 report. Across the last 8 reports, EQIX beat estimates in 6.
EQIX stays in a downtrend while it sits below its 50-day average of $1,027.97 and its 200-day average of $1,006.37. A close back above the 200-day average would be the first sign of repair. The 20-day EMA, at $996.75, is the first hurdle overhead.
The next level below the price is the 52-week low at $720.62. With the RSI in the bearish band, momentum argues against a fast rebound.
Technical indicators
Momentum and trend for EQIX, from its daily closes.
As of October 26, 2026, with EQIX at $967.65, its 14-day RSI is 39.3 (showing bearish momentum without being oversold), its 50-day simple moving average is $1,027.97 and its 200-day is $1,006.37.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What EQIX moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, EQIX's 1-year correlation of daily returns is +0.42 with S&P 500 (SPY), +0.38 with Nasdaq 100 (QQQ), +0.21 with Bitcoin (BTC) and +0.11 with gold (XAU).
EQIX price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
30 of 35 analysts rate it a buy or strong buy, 5 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $1,237.50 is 27.9% above the price.More buy ratings than three months ago ›
30 of 35 rate it a buy now, against 26 of 32 three months ago.
EQIX Wall Street View
12-month price targets
The price, $967.65, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 21, 2026 | CIBC | Initiates | Outperformer |
| Oct 20, 2026 | Guggenheim | Reiterates | Buy |
| Sep 21, 2026 | Rothschild & Co | Initiates | Buy |
| Sep 10, 2026 | BTIG | Maintains | Buy |
| Sep 8, 2026 | Barclays | Maintains | Equal-Weight |
| Aug 18, 2026 | Evercore ISI Group | Maintains | Outperform |
As of October 26, 2026, 35 Wall Street analysts cover EQIX: 30 rate it a buy or strong buy, 5 a hold and 0 a sell or strong sell. Their 12-month price targets range from $1,060.00 to $1,380.00. The median EQIX price target is $1,237.50, 27.9% above the price of $967.65.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
EQIX trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
EQIX trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from EQIX's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much EQIX tends to move, against the market and on its own.
EQIX price history and drawdowns
EQIX's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.58% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 39.2%, from September 2021 to October 2022, regained by February 2024.Most 1-year holds ended higher ›
74% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $33,345, against $42,015 in the S&P 500 (SPY).
EQIX Drawdowns & Recovery
As of October 26, 2026, EQIX's worst peak-to-trough fall over the last 10 years with dividends reinvested was -39.2% (September 2021 to October 2022); it regained that peak by February 2024, 16 months after the low, and 74% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into EQIX in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: EQIX trailed the S&P 500 over this period: $33,345 against $42,015.
A $10,000 investment in EQIX in October 2016 would be worth about $33,345 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to EQIX, and which have not.
Strongest month, August: an average of +3.55%, up in 9 of 10 years.
Weakest month, September: an average of -2.68%, up in 4 of 10 years.
This month, October: has averaged +0.08%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, EQIX's strongest calendar month has been August (average +3.55%, up in 9 of 10 years) and its weakest September (average -2.68%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
EQIX stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in EQIX, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in EQIX today could grow to about $13,593 by 2030 in the base case, with a 90th-percentile outcome near $27,430 and a 10th-percentile outcome around $6,736. The simulation models price only; at today's 2.08% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
EQIX Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $1,315 for EQIX by 2030 in the base case, from $968 today (1.4x over 4 years). The 10th-percentile path ends near $652. These are outcomes of a Monte Carlo simulation run on EQIX's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $736 | $1,045 | $1,484 | |
| 2028 | $687 | $1,128 | $1,853 | |
| 2029 | $663 | $1,218 | $2,238 | |
| 2030 | $652 | $1,315 | $2,654 |
Method: a lognormal simulation of EQIX's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
EQIX insider trading
What the people running the company have bought and sold.
EQIX insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought EQIX shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 26, 2026, EQIX insiders reported 63 open-market sales worth $66.0M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Michael Shane Paladin
Officer
|
Sell | 307 | $317.7K |
| Sep 2, 2026 | Michael Shane Paladin
Officer
|
Sell | 203 | $206.2K |
| Sep 1, 2026 | Michael Shane Paladin
Officer
|
Grant | 510 | - |
| Aug 20, 2026 | Kurt Pletcher
Officer
|
Sell | 135 | $145.2K |
| Aug 18, 2026 | Christopher B. Paisley
Director
|
Sell | 125 | $137.9K |
| Aug 3, 2026 | Christopher B. Paisley
Director
|
Sell | 4.0K | $4.1M |
| Jun 8, 2026 | Brandi Galvin Morandi
Officer
|
Sell | 3.7K | $4.0M |
| Jun 2, 2026 | Adaire Fox-Martin
Chief Executive Officer
|
Sell | 2.9K | $3.1M |
| Jun 2, 2026 | Raouf F Abdel
Officer
|
Sell | 158 | $167.8K |
| Jun 2, 2026 | Jonathan Lin
Officer
|
Sell | 150 | $159.3K |
| Jun 2, 2026 | Kurt Pletcher
Officer
|
Sell | 79 | $84.0K |
| Jun 1, 2026 | Raouf F Abdel
Officer
|
Grant | 364 | - |
| Jun 1, 2026 | Adaire Fox-Martin
Chief Executive Officer
|
Grant | 5.6K | - |
| Jun 1, 2026 | Jonathan Lin
Officer
|
Grant | 273 | - |
| Jun 1, 2026 | Kurt Pletcher
Officer
|
Grant | 182 | - |
| May 22, 2026 | Raouf F Abdel
Officer
|
Sell | 2.0K | $2.2M |
| May 21, 2026 | Gary F Hromadko
Director
|
Grant | 302 | - |
| May 21, 2026 | Rebecca J. Kujawa
Director
|
Grant | 170 | - |
| May 21, 2026 | Yanbing Li
Director
|
Grant | 255 | - |
| May 21, 2026 | Thomas S Olinger
Director
|
Grant | 302 | - |
| May 21, 2026 | Christopher B. Paisley
Director
|
Grant | 302 | - |
| May 21, 2026 | Fidelma Russo
Director
|
Grant | 302 | - |
| May 18, 2026 | Christopher B. Paisley
Director
|
Sell | 125 | $132.5K |
| May 6, 2026 | Charles John Meyers
Director
|
Sell | 5.2K | $5.7M |
| May 6, 2026 | Brandi Galvin Morandi
Officer
|
Grant | 112 | - |
| Apr 8, 2026 | Brandi Galvin Morandi
Officer
|
Sell | 424 | $432.5K |
| Mar 12, 2026 | Adaire Fox-Martin
Chief Executive Officer
|
Sell | 1.1K | $1.0M |
| Mar 12, 2026 | Keith David Taylor
Chief Financial Officer
|
Sell | 760 | $730.5K |
| Mar 12, 2026 | Jonathan Lin
Officer
|
Sell | 635 | $613.2K |
| Mar 12, 2026 | Brandi Galvin Morandi
Officer
|
Sell | 630 | $605.6K |
| Mar 12, 2026 | Raouf F Abdel
Officer
|
Sell | 584 | $564.0K |
| Mar 12, 2026 | Kurt Pletcher
Officer
|
Sell | 559 | $539.8K |
| Mar 12, 2026 | Charles John Meyers
Director
|
Sell | 305 | $293.2K |
| Mar 12, 2026 | Simon Miller
Officer
|
Sell | 289 | $279.1K |
| Mar 12, 2026 | Michael Shane Paladin
Officer
|
Sell | 118 | $114.1K |
| Mar 11, 2026 | Raouf F Abdel
Officer
|
Grant | 584 | - |
| Mar 11, 2026 | Adaire Fox-Martin
Chief Executive Officer
|
Grant | 2.0K | - |
| Mar 11, 2026 | Jonathan Lin
Officer
|
Grant | 635 | - |
| Mar 11, 2026 | Charles John Meyers
Director
|
Grant | 305 | - |
| Mar 11, 2026 | Simon Miller
Officer
|
Grant | 287 | - |
| Mar 11, 2026 | Brandi Galvin Morandi
Officer
|
Grant | 630 | - |
| Mar 11, 2026 | Michael Shane Paladin
Officer
|
Grant | 297 | - |
| Mar 11, 2026 | Kurt Pletcher
Officer
|
Grant | 559 | - |
| Mar 11, 2026 | Keith David Taylor
Chief Financial Officer
|
Grant | 760 | - |
| Mar 4, 2026 | Charles John Meyers
Director
|
Sell | 2.7K | $2.6M |
| Mar 3, 2026 | Raouf F Abdel
Officer
|
Sell | 1.1K | $1.1M |
| Mar 3, 2026 | Simon Miller
Officer
|
Sell | 422 | $404.8K |
| Mar 3, 2026 | Kurt Pletcher
Officer
|
Sell | 317 | $305.9K |
| Mar 3, 2026 | Michael Shane Paladin
Officer
|
Sell | 208 | $198.7K |
| Mar 2, 2026 | Simon Miller
Officer
|
Grant | 1.1K | - |
| Mar 2, 2026 | Michael Shane Paladin
Officer
|
Grant | 510 | - |
| Mar 2, 2026 | Kurt Pletcher
Officer
|
Grant | 142 | - |
| Feb 18, 2026 | Adaire Fox-Martin
Chief Executive Officer
|
Sell | 4.2K | $3.9M |
| Feb 18, 2026 | Keith David Taylor
Chief Financial Officer
|
Sell | 2.4K | $2.3M |
| Feb 18, 2026 | Charles John Meyers
Director
|
Sell | 1.6K | $1.5M |
| Feb 18, 2026 | Brandi Galvin Morandi
Officer
|
Sell | 1.6K | $1.5M |
| Feb 18, 2026 | Raouf F Abdel
Officer
|
Sell | 1.2K | $1.1M |
| Feb 18, 2026 | Jonathan Lin
Officer
|
Sell | 1.1K | $1.1M |
| Feb 18, 2026 | Kurt Pletcher
Officer
|
Sell | 823 | $774.0K |
| Feb 18, 2026 | Michael Shane Paladin
Officer
|
Sell | 673 | $628.7K |
| Feb 18, 2026 | Christopher B. Paisley
Director
|
Sell | 100 | $94.8K |
| Feb 17, 2026 | Raouf F Abdel
Officer
|
Grant | 2.7K | - |
| Feb 17, 2026 | Adaire Fox-Martin
Chief Executive Officer
|
Grant | 8.0K | - |
| Feb 17, 2026 | Jonathan Lin
Officer
|
Grant | 2.5K | - |
| Feb 17, 2026 | Charles John Meyers
Director
|
Grant | 3.6K | - |
| Feb 17, 2026 | Brandi Galvin Morandi
Officer
|
Grant | 3.0K | - |
| Feb 17, 2026 | Michael Shane Paladin
Officer
|
Grant | 1.6K | - |
| Feb 17, 2026 | Kurt Pletcher
Officer
|
Grant | 1.9K | - |
| Feb 17, 2026 | Keith David Taylor
Chief Financial Officer
|
Grant | 4.6K | - |
| Feb 12, 2026 | Keith David Taylor
Chief Financial Officer
|
Sell | 2.0K | $1.9M |
| Feb 12, 2026 | Brandi Galvin Morandi
Officer
|
Sell | 600 | $579.4K |
| Jan 16, 2026 | Adaire Fox-Martin
Chief Executive Officer
|
Sell | 2.7K | $2.1M |
| Jan 16, 2026 | Charles John Meyers
Director
|
Sell | 2.1K | $1.7M |
| Jan 16, 2026 | Keith David Taylor
Chief Financial Officer
|
Sell | 2.1K | $1.6M |
| Jan 16, 2026 | Brandi Galvin Morandi
Officer
|
Sell | 1.3K | $1.1M |
| Jan 16, 2026 | Raouf F Abdel
Officer
|
Sell | 927 | $743.3K |
| Jan 16, 2026 | Jonathan Lin
Officer
|
Sell | 888 | $712.4K |
| Jan 16, 2026 | Kurt Pletcher
Officer
|
Sell | 595 | $477.7K |
| Jan 16, 2026 | Michael Shane Paladin
Officer
|
Sell | 327 | $263.0K |
| Jan 15, 2026 | Raouf F Abdel
Officer
|
Grant | 2.1K | - |
| Jan 15, 2026 | Adaire Fox-Martin
Chief Executive Officer
|
Grant | 5.2K | - |
| Jan 15, 2026 | Jonathan Lin
Officer
|
Grant | 2.0K | - |
| Jan 15, 2026 | Charles John Meyers
Director
|
Grant | 4.9K | - |
| Jan 15, 2026 | Brandi Galvin Morandi
Officer
|
Grant | 2.6K | - |
| Jan 15, 2026 | Michael Shane Paladin
Officer
|
Grant | 777 | - |
| Jan 15, 2026 | Kurt Pletcher
Officer
|
Grant | 1.4K | - |
| Jan 15, 2026 | Keith David Taylor
Chief Financial Officer
|
Grant | 4.0K | - |
| Dec 10, 2025 | Raouf F Abdel
Officer
|
Sell | 403 | $298.2K |
| Dec 10, 2025 | Raouf F Abdel
Officer
|
Grant | 50 | - |
| Dec 2, 2025 | Adaire Fox-Martin
Chief Executive Officer
|
Sell | 2.9K | $2.1M |
| Dec 2, 2025 | Kurt Pletcher
Officer
|
Sell | 290 | $212.4K |
| Dec 2, 2025 | Raouf F Abdel
Officer
|
Sell | 159 | $116.4K |
| Dec 2, 2025 | Jonathan Lin
Officer
|
Sell | 123 | $90.5K |
| Dec 1, 2025 | Raouf F Abdel
Officer
|
Grant | 365 | - |
| Dec 1, 2025 | Adaire Fox-Martin
Chief Executive Officer
|
Grant | 5.6K | - |
| Dec 1, 2025 | Jonathan Lin
Officer
|
Grant | 274 | - |
| Dec 1, 2025 | Kurt Pletcher
Officer
|
Grant | 696 | - |
| Nov 18, 2025 | Christopher B. Paisley
Director
|
Sell | 50 | $38.9K |
| Nov 17, 2025 | Charles John Meyers
Director
|
Sell | 5.1K | $4.0M |
| Nov 3, 2025 | Brandi Galvin Morandi
Officer
|
Sell | 100 | $84.0K |
| Oct 7, 2025 | Michael Shane Paladin
Officer
|
Grant | 824 | - |
| Sep 9, 2025 | Raouf F Abdel
Officer
|
Sell | 404 | $311.5K |
| Sep 3, 2025 | Simon Miller
Officer
|
Sell | 561 | $427.9K |
| Sep 3, 2025 | Kurt Pletcher
Officer
|
Sell | 58 | $44.6K |
| Sep 2, 2025 | Simon Miller
Officer
|
Grant | 1.1K | - |
| Sep 2, 2025 | Kurt Pletcher
Officer
|
Grant | 142 | - |
| Aug 18, 2025 | Christopher B. Paisley
Director
|
Sell | 75 | $58.6K |
| Jun 3, 2025 | Adaire Fox-Martin
Chief Executive Officer
|
Sell | 2.9K | $2.6M |
| Jun 2, 2025 | Raouf F Abdel
Officer
|
Grant | 365 | - |
| Jun 2, 2025 | Adaire Fox-Martin
Chief Executive Officer
|
Grant | 5.6K | - |
| Jun 2, 2025 | Jonathan Lin
Officer
|
Grant | 274 | - |
| Jun 2, 2025 | Kurt Pletcher
Officer
|
Grant | 183 | - |
| May 23, 2025 | Gary F Hromadko
Director
|
Grant | 338 | - |
| May 23, 2025 | Thomas S Olinger
Director
|
Grant | 338 | - |
| May 23, 2025 | Christopher B. Paisley
Director
|
Grant | 338 | - |
| May 23, 2025 | Fidelma Russo
Director
|
Grant | 338 | - |
| May 22, 2025 | Raouf F Abdel
Officer
|
Sell | 1.3K | $1.1M |
| May 21, 2025 | Jeetendra I Patel
Director
|
Grant | 338 | - |
| May 16, 2025 | Christopher B. Paisley
Director
|
Sell | 100 | $86.9K |
| May 7, 2025 | Kurt Pletcher
Officer
|
Sell | 127 | $111.5K |
Source: TwelveData, from SEC Form 4 filings
EQIX stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.